Matrices and scaffolds for DNA delivery in tissue engineering

Advanced Drug Delivery Reviews

Volumn 59, Issue 4-5, 2007, Pages 292-307

  De Laporte, Laura ^a   Shea, Lonnie D ^a,b  

^a Northwestern University   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

biomaterials; gene therapy; regenerative medicine

Indexed keywords

CELLS; DRUG DELIVERY; IMPLANTS (SURGICAL); SCAFFOLDS;

GENE THERAPY; REGENERATIVE MEDICINE; TISSUE ENGINEERING SCAFFOLDS; TRANSGENE EXPRESSION;

TISSUE ENGINEERING;

BIOMATERIAL; DNA; POLYMER; SCAFFOLD PROTEIN;

CELL DIFFERENTIATION; CELL FUNCTION; CELL TRANSPLANTATION; CONCENTRATION (PARAMETERS); DRUG DELIVERY SYSTEM; ENCAPSULATION; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; HYDROGEL; IMMOBILIZATION; INFLAMMATION; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; SHUTTLE VECTOR; STEM CELL; THERMOREGULATION; TISSUE ENGINEERING; TRANSGENE;

BIOCOMPATIBLE MATERIALS; DNA; DRUG DELIVERY SYSTEMS; GENE TRANSFER TECHNIQUES; HUMANS; HYDROGEL; TISSUE ENGINEERING;

EID: 34249947638     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2007.03.017     Document Type: Review

References (188)

1. Langer R. Drug delivery and targeting. Nature 392 (1998) 5-10
2. Langer R. Drug delivery. Drugs on target. Science 293 (2001) 58-59
3. Salvay D.M., and Shea L.D. Inductive tissue engineering with protein and DNA-releasing scaffolds. Mol. Biosyst. 2 (2006) 36-48
4. Pannier A.K., and Shea L.D. Controlled release systems for DNA delivery. Mol. Ther. 10 (2004) 19-26
5. Bumcrot D., Manoharan M., Koteliansky V., and Sah D.W. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat. Chem. Biol. 2 (2006) 711-719
6. Middaugh C.R., Evans R.K., Montgomery D.L., and Casimiro D.R. Analysis of plasmid DNA from a pharmaceutical perspective. J. Pharm. Sci. 87 (1998) 130-146
7. Medzhitov R., and Janeway Jr. C.A. Decoding the patterns of self and nonself by the innate immune system. Science 296 (2002) 298-300
8. Yang Y., Ertl H.C., and Wilson J.M. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1 (1994) 433-442
9. Zhang X., and Godbey W.T. Viral vectors for gene delivery in tissue engineering. Adv. Drug Deliv. Rev. 58 (2006) 515-534
10. Roth C.M., and Sundaram S. Engineering synthetic vectors for improved DNA delivery: insights from intracellular pathways. Annu. Rev. Biomed. Eng. 6 (2004) 397-426
11. Pack D.W., Hoffman A.S., Pun S., and Stayton P.S. Design and development of polymers for gene delivery. Nat. Rev. Drug Discov. 4 (2005) 581-593
12. Kootstra N.A., and Verma I.M. Gene therapy with viral vectors. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 413-439
13. Putnam D., and Doody A. RNA-interference effectors and their delivery. Crit. Rev. Ther. Drug Carr. Syst. 23 (2006) 137-164
14. Spagnou S., Miller A.D., and Keller M. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Biochemistry 43 (2004) 13348-13356
15. De Laporte L., Cruz Rea J., and Shea L.D. Design of modular non-viral gene therapy vectors. Biomaterials 27 (2006) 947-954
16. Storrie H., and Mooney D.J. Sustained delivery of plasmid DNA from polymeric scaffolds for tissue engineering. Adv. Drug Deliv. Rev. 58 (2006) 500-514
17. Bessis N., GarciaCozar F.J., and Boissier M.C. Immune responses to gene therapy vectors: influence on vector function and effector mechanisms. Gene Ther. 11 Suppl 1 (2004) S10-S17
18. Nazir S.A., and Metcalf J.P. Innate immune response to adenovirus. J. Investig. Med. 53 (2005) 292-304
19. Alden T.D., Pittman D.D., Hankins G.R., Beres E.J., Engh J.A., Das S., Hudson S.B., Kerns K.M., Kallmes D.F., and Helm G.A. In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector. Hum. Gene Ther. 10 (1999) 2245-2253
20. Knoller N., Auerbach G., Fulga V., Zelig G., Attias J., Bakimer R., Marder J.B., Yoles E., Belkin M., Schwartz M., and Hadani M. Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results. J. Neurosurg. Spine 3 (2005) 173-181
21. Okubo Y., Bessho K., Fujimura K., Iizuka T., and Miyatake S.I. Osteoinduction by bone morphogenetic protein-2 via adenoviral vector under transient immunosuppression. Biochem. Biophys. Res. Commun. 267 (2000) 382-387
22. Schwartz M., and Yoles E. Macrophages and dendritic cells treatment of spinal cord injury: from the bench to the clinic. Acta Neurochir., Suppl. 93 (2005) 147-150
23. Vilaboa N., and Voellmy R. Regulatable gene expression systems for gene therapy. Curr. Gene Ther. 6 (2006) 421-438
24. Jackson D.A., Juranek S., and Lipps H.J. Designing nonviral vectors for efficient gene transfer and long-term gene expression. Mol. Ther. 14 (2006) 613-626
25. Maheshri N., Koerber J.T., Kaspar B.K., and Schaffer D.V. Directed evolution of adeno-associated virus yields enhanced gene delivery vectors. Nat. Biotechnol. 24 (2006) 198-204
26. Perabo L., Endell J., King S., Lux K., Goldnau D., Hallek M., and Buning H. Combinatorial engineering of a gene therapy vector: directed evolution of adeno-associated virus. J. Gene Med. 8 (2006) 155-162
27. Wright A., Semyonov A., Dawes G., Crameri A., Lyons R., Stemmer W.P., Apt D., and Punnonen J. Diverse plasmid DNA vectors by directed molecular evolution of cytomegalovirus promoters. Hum. Gene Ther. 16 (2005) 881-892
28. Anderson D.G., Lynn D.M., and Langer R. Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery. Angew. Chem., Int. Ed. Engl. 42 (2003) 3153-3158
29. Wood K.C., Little S.R., Langer R., and Hammond P.T. A family of hierarchically self-assembling linear-dendritic hybrid polymers for highly efficient targeted gene delivery. Angew. Chem., Int. Ed. Engl. 44 (2005) 6704-6708
30. Romanczuk H., Galer C.E., Zabner J., Barsomian G., Wadsworth S.C., and O'Riordan C.R. Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice. Hum. Gene Ther. 10 (1999) 2615-2626
31. Croyle M.A., Chirmule N., Zhang Y., and Wilson J.M. "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung. J. Virol. 75 (2001) 4792-4801
32. Ritter T., Lehmann M., and Volk H.D. Improvements in gene therapy: averting the immune response to adenoviral vectors. BioDrugs 16 (2002) 3-10
33. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., and Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374 (1995) 546-549
34. Varga C.M., Tedford N.C., Thomas M., Klibanov A.M., Griffith L.G., and Lauffenburger D.A. Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes. Gene Ther. 12 (2005) 1023-1032
35. Oishi M., Kataoka K., and Nagasaki Y. pH-responsive three-layered PEGylated polyplex micelle based on a lactosylated ABC triblock copolymer as a targetable and endosome-disruptive nonviral gene vector. Bioconjug. Chem. 17 (2006) 677-688
36. Asayama S., Hamaya A., Sekine T., Kawakami H., and Nagaoka S. Aminated poly(l-histidine) as new pH-sensitive DNA carrier. Nucleic Acids Symp. Ser. (Oxf). (2004) 229-230
37. Oupicky D., Carlisle R.C., and Seymour L.W. Triggered intracellular activation of disulfide crosslinked polyelectrolyte gene delivery complexes with extended systemic circulation in vivo. Gene Ther. 8 (2001) 713-724
38. Yang J., Chen H., Vlahov I.R., Cheng J.X., and Low P.S. Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 13872-13877
39. McKenzie D.L., Smiley E., Kwok K.Y., and Rice K.G. Low molecular weight disulfide cross-linking peptides as nonviral gene delivery carriers. Bioconjug. Chem. 11 (2000) 901-909
40. Chen C.P., Kim J.S., Steenblock E., Liu D., and Rice K.G. Gene transfer with poly-melittin peptides. Bioconjug. Chem. 17 (2006) 1057-1062
41. Dean D.A., Strong D.D., and Zimmer W.E. Nuclear entry of nonviral vectors. Gene Ther. 12 (2005) 881-890
42. Z. Bengali, L.D. Shea, Cellular Association and Distribution of DNA Delivered by Immobilization to a Culture Substrate, (submitted for publication).
43. Garcia A.J. Get a grip: integrins in cell-biomaterial interactions. Biomaterials 26 (2005) 7525-7529
44. Georges P.C., and Janmey P.A. Cell type-specific response to growth on soft materials. J. Appl. Physiol. 98 (2005) 1547-1553
45. Engler A.J., Sen S., Sweeney H.L., and Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 126 (2006) 677-689
46. Paszek M.J., and Weaver V.M. The tension mounts: mechanics meets morphogenesis and malignancy. J. Mammary Gland Biol. Neoplasia 9 (2004) 325-342
47. Yeung T., Georges P.C., Flanagan L.A., Marg B., Ortiz M., Funaki M., Zahir N., Ming W., Weaver V., and Janmey P.A. Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. Cell Motil. Cytoskelet. 60 (2005) 24-34
48. Xu M., West E., Shea L.D., and Woodruff T.K. Identification of a stage-specific permissive in vitro culture environment for follicle growth and oocyte development. Biol. Reprod. 75 (2006) 916-923
49. Powers M.J., Domansky K., Kaazempur-Mofrad M.R., Kalezi A., Capitano A., Upadhyaya A., Kurzawski P., Wack K.E., Stolz D.B., Kamm R., and Griffith L.G. A microfabricated array bioreactor for perfused 3D liver culture. Biotechnol. Bioeng. 78 (2002) 257-269
50. Roy K., Wang D., Hedley M.L., and Barman S.P. Gene delivery with in-situ crosslinking polymer networks generates long-term systemic protein expression. Mol. Ther. 7 (2003) 401-408
51. Schek R.M., Hollister S.J., and Krebsbach P.H. Delivery and protection of adenoviruses using biocompatible hydrogels for localized gene therapy. Mol. Ther. 9 (2004) 130-138
52. Jang J.H., and Shea L.D. Controllable delivery of non-viral DNA from porous scaffolds. J. Control. Release 86 (2003) 157-168
53. Batycky R.P., Hanes J., Langer R., and Edwards D.A. A theoretical model of erosion and macromolecular drug release from biodegrading microspheres. J. Pharm. Sci. 86 (1997) 1464-1477
54. Luo D., Woodrow-Mumford K., Belcheva N., and Saltzman W.M. Controlled DNA delivery systems. Pharm. Res. 16 (1999) 1300-1308
55. Harris L.D., Kim B.S., and Mooney D.J. Open pore biodegradable matrices formed with gas foaming. J. Biomed. Mater. Res. 42 (1998) 396-402
56. Shea L.D., Smiley E., Bonadio J., and Mooney D.J. DNA delivery from polymer matrices for tissue engineering. Nat. Biotechnol. 17 (1999) 551-554
57. L.D. Shea, unpublished observation.
58. L. De Laporte, Y. Yang, M.L. Zelivyanskaya, A.J. Anderson, L.D. Shea, DNA loaded multiple channel bridges for spinal cord regeneration, (in preparation).
59. Huang Y.C., Simmons C., Kaigler D., Rice K.G., and Mooney D.J. Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4). Gene Ther. 12 (2005) 418-426
60. Jang J.H., Rives C.B., and Shea L.D. Plasmid delivery in vivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection. Mol. Ther. 12 (2005) 475-483
61. Huang Y.C., Connell M., Park Y., Mooney D.J., and Rice K.G. Fabrication and in vitro testing of polymeric delivery system for condensed DNA. J. Biomed. Mater. Res. A 67 (2003) 1384-1392
62. Huang Y.C., Riddle K., Rice K.G., and Mooney D.J. Long-term in vivo gene expression via delivery of PEI-DNA condensates from porous polymer scaffolds. Hum. Gene Ther. 16 (2005) 609-617
63. Liang D., Luu Y.K., Kim K., Hsiao B.S., Hadjiargyrou M., and Chu B. In vitro non-viral gene delivery with nanofibrous scaffolds. Nucleic Acids Res. 33 (2005) e170
64. Luu Y.K., Kim K., Hsiao B.S., Chu B., and Hadjiargyrou M. Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers. J. Control. Release 89 (2003) 341-353
65. Chun K.W., Cho K.C., Kim S.H., Jeong J.H., and Park T.G. Controlled release of plasmid DNA from biodegradable scaffolds fabricated using a thermally-induced phase-separation method. J. Biomater. Sci., Polym. Ed. 15 (2004) 1341-1353
66. Eliaz R.E., and Szoka Jr. F.C. Robust and prolonged gene expression from injectable polymeric implants. Gene Ther. 9 (2002) 1230-1237
67. Lutolf M.P., and Hubbell J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 23 (2005) 47-55
68. Anseth K.S., Bowman C.N., and Brannon-Peppas L. Mechanical properties of hydrogels and their experimental determination. Biomaterials 17 (1996) 1647-1657
69. Kasper F.K., Seidlits S.K., Tang A., Crowther R.S., Carney D.H., Barry M.A., and Mikos A.G. In vitro release of plasmid DNA from oligo(poly(ethylene glycol) fumarate) hydrogels. J. Control. Release 104 (2005) 521-539
70. J. Wieland, T. Houchin-Ray, L.D. Shea, Non-viral vector delivery from PEG-hyaluronic acid hydrogels, J. Control. Release (in press).
71. Ledley F.D. Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum. Gene Ther. 6 (1995) 1129-1144
72. Jabbari E. Release characteristics of a model plasmid DNA encapsulated in biodegradable poly(ethylene glycol fumarate)/acrylamide hydrogel microspheres. J. Microencapsul 21 (2004) 525-538
73. Scherer F., Schillinger U., Putz U., Stemberger A., and Plank C. Nonviral vector loaded collagen sponges for sustained gene delivery in vitro and in vivo. J. Gene Med. 4 (2002) 634-643
74. Fang J., Zhu Y.Y., Smiley E., Bonadio J., Rouleau J.P., Goldstein S.A., McCauley L.K., Davidson B.L., and Roessler B.J. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 5753-5758
75. Bonadio J., Smiley E., Patil P., and Goldstein S. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat. Med. 5 (1999) 753-759
76. Chandler L.A., Doukas J., Gonzalez A.M., Hoganson D.K., Gu D.L., Ma C., Nesbit M., Crombleholme T.M., Herlyn M., Sosnowski B.A., and Pierce G.F. FGF2-Targeted adenovirus encoding platelet-derived growth factor-B enhances de novo tissue formation. Mol. Ther. 2 (2000) 153-160
77. Chandler L.A., Gu D.L., Ma C., Gonzalez A.M., Doukas J., Nguyen T., Pierce G.F., and Phillips M.L. Matrix-enabled gene transfer for cutaneous wound repair. Wound Repair Regen. 8 (2000) 473-479
78. Chandler L.A., and Sosnowski B.A. Gene therapy for cutaneous wound repair. Wounds 16 (2004) 23-33
79. Doukas J., Chandler L.A., Gonzalez A.M., Gu D., Hoganson D.K., Ma C., Nguyen T., Printz M.A., Nesbit M., Herlyn M., Crombleholme T.M., Aukerman S.L., Sosnowski B.A., and Pierce G.F. Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors. Hum. Gene Ther. 12 (2001) 783-798
80. Tyrone J.W., Mogford J.E., Chandler L.A., Ma C., Xia Y., Pierce G.F., and Mustoe T.A. Collagen-embedded platelet-derived growth factor DNA plasmid promotes wound healing in a dermal ulcer model. J. Surg. Res. 93 (2000) 230-236
81. Doukas J., Blease K., Craig D., Ma C., Chandler L.A., Sosnowski B.A., and Pierce G.F. Delivery of FGF genes to wound repair cells enhances arteriogenesis and myogenesis in skeletal muscle. Mol. Ther. 5 (2002) 517-527
82. Berry M., Gonzalez A.M., Clarke W., Greenlees L., Barrett L., Tsang W., Seymour L., Bonadio J., Logan A., and Baird A. Sustained effects of gene-activated matrices after CNS injury. Mol. Cell. Neurosci. 17 (2001) 706-716
83. Ochiya T., Takahama Y., Nagahara S., Sumita Y., Hisada A., Itoh H., Nagai Y., and Terada M. New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet. Nat. Med. 5 (1999) 707-710
84. Hanai K., Takeshita F., Honma K., Nagahara S., Maeda M., Minakuchi Y., Sano A., and Ochiya T. Atelocollagen-Mediated Systemic DDS for Nucleic Acid Medicines. Ann. N. Y. Acad. Sci. 1082 (2006) 9-17
85. Minakuchi Y., Takeshita F., Kosaka N., Sasaki H., Yamamoto Y., Kouno M., Honma K., Nagahara S., Hanai K., Sano A., Kato T., Terada M., and Ochiya T. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. Nucleic Acids Res. 32 (2004) e109
86. Cohen-Sacks H., Elazar V., Gao J., Golomb A., Adwan H., Korchov N., Levy R.J., Berger M.R., and Golomb G. Delivery and expression of pDNA embedded in collagen matrices. J. Control. Release 95 (2004) 309-320
87. Fukunaka Y., Iwanaga K., Morimoto K., Kakemi M., and Tabata Y. Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation. J. Control. Release 80 (2002) 333-343
88. Kushibiki T., Tomoshige R., Fukunaka Y., Kakemi M., and Tabata Y. In vivo release and gene expression of plasmid DNA by hydrogels of gelatin with different cationization extents. J. Control. Release 90 (2003) 207-216
89. Sakamoto H., Ochiya T., Sato Y., Tsukamoto M., Konishi H., Saito I., Sugimura T., and Terada M. Adenovirus-mediated transfer of the HST-1 (FGF4) gene induces increased levels of platelet count in vivo. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 12368-12372
90. Siemens D.R., Austin J.C., Hedican S.P., Tartaglia J., and Ratliff T.L. Viral vector delivery in solid-state vehicles: gene expression in a murine prostate cancer model. J. Natl. Cancer Inst. 92 (2000) 403-412
91. Quick D.J., and Anseth K.S. Gene delivery in tissue engineering: a photopolymer platform to coencapsulate cells and plasmid DNA. Pharm. Res. 20 (2003) 1730-1737
92. Quick D.J., and Anseth K.S. DNA delivery from photocrosslinked PEG hydrogels: encapsulation efficiency, release profiles, and DNA quality. J. Control. Release 96 (2004) 341-351
93. Chun K.W., Lee J.B., Kim S.H., and Park T.G. Controlled release of plasmid DNA from photo-cross-linked pluronic hydrogels. Biomaterials 26 (2005) 3319-3326
94. Megeed Z., Cappello J., and Ghandehari H. Controlled release of plasmid DNA from a genetically engineered silk-elastinlike hydrogel. Pharm. Res. 19 (2002) 954-959
95. Megeed Z., Haider M., Li D., O'Malley Jr. B.W., Cappello J., and Ghandehari H. In vitro and in vivo evaluation of recombinant silk-elastinlike hydrogels for cancer gene therapy. J. Control. Release 94 (2004) 433-445
96. Breen A., Strappe P., Kumar A., O'Brien T., and Pandit A. Optimization of a fibrin scaffold for sustained release of an adenoviral gene vector. J. Biomed. Mater. Res. A 78 (2006) 702-708
97. Bajaj B., Lei P., and Andreadis S.T. High efficiencies of gene transfer with immobilized recombinant retrovirus: kinetics and optimization. Biotechnol. Prog. 17 (2001) 587-596
98. Proctor R.A. Fibronectin: a brief overview of its structure, function, and physiology. Rev. Infect. Dis. 9 Suppl 4 (1987) S317-S321
99. Levy R.J., Song C., Tallapragada S., DeFelice S., Hinson J.T., Vyavahare N., Connolly J., Ryan K., and Li Q. Localized adenovirus gene delivery using antiviral IgG complexation. Gene Ther. 8 (2001) 659-667
100. Segura T., and Shea L.D. Surface-tethered DNA complexes for enhanced gene delivery. Bioconjug. Chem. 13 (2002) 621-629
101. Norde W., and Lyklema J. Why proteins prefer interfaces. J. Biomater. Sci., Polym. Ed. 2 (1991) 183-202
102. Bengali Z., Pannier A.K., Segura T., Anderson B.C., Jang J.H., Mustoe T.A., and Shea L.D. Gene delivery through cell culture substrate adsorbed DNA complexes. Biotechnol. Bioeng. 90 (2005) 290-302
103. A.K. Pannier, J.A. Wieland, L.D. Shea, Incorporation of polyethylene glycol into self-assembled monolayers enhances substrate-mediated gene delivery by nonspecifically-bound complexes, (submitted for publication).
104. Jang J.H., Bengali Z., Houchin T.L., and Shea L.D. Surface adsorption of DNA to tissue engineering scaffolds for efficient gene delivery. J. Biomed. Mater. Res. A 77 (2006) 50-58
105. Nie Y., Zhang Z.R., and Duan Y.R. Combined use of polycationic peptide and biodegradable macromolecular polymer as a novel gene delivery system: a preliminary study. Drug Deliv. 13 (2006) 441-446
106. Singh M., Fang J.H., Kazzaz J., Ugozzoli M., Chesko J., Malyala P., Dhaliwal R., Wei R., Hora M., and O'Hagan D. A modified process for preparing cationic polylactide-co-glycolide microparticles with adsorbed DNA. Int. J. Pharm. 327 (2006) 1-5
107. Zheng J., Manuel W.S., and Hornsby P.J. Transfection of cells mediated by biodegradable polymer materials with surface-bound polyethyleneimine. Biotechnol. Prog. 16 (2000) 254-257
108. Kumta P.N., Sfeir C., Lee D.H., Olton D., and Choi D. Nanostructured calcium phosphates for biomedical applications: novel synthesis and characterization. Acta Biomater. 1 (2005) 65-83
109. Olton D., Li J., Wilson M.E., Rogers T., Close J., Huang L., Kumta P.N., and Sfeir C. Nanostructured calcium phosphates (NanoCaPs) for non-viral gene delivery: Influence of the synthesis parameters on transfection efficiency. Biomaterials 28 (2007) 1267-1279
110. Shen H., Tan J., and Saltzman W.M. Surface-mediated gene transfer from nanocomposites of controlled texture. Nat. Mater. 3 (2004) 569-574
111. Segura T., Chung P.H., and Shea L.D. DNA delivery from hyaluronic acid-collagen hydrogels via a substrate-mediated approach. Biomaterials 26 (2005) 1575-1584
112. Stachelek S.J., Song C., Alferiev I., Defelice S., Cui X., Connolly J.M., Bianco R.W., and Levy R.J. Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants. Gene Ther. 11 (2004) 15-24
113. Hammond P.T. Form and function in multi-layer assembly: new applications at the nanoscale. Adv. Mater. 16 (2004) 1271-1293
114. Jewell C.M., Zhang J., Fredin N.J., and Lynn D.M. Multilayered polyelectrolyte films promote the direct and localized delivery of DNA to cells. J. Control. Release 106 (2005) 214-223
115. Jewell C.M., Zhang J., Fredin N.J., Wolff M.R., Hacker T.A., and Lynn D.M. Release of plasmid DNA from intravascular stents coated with ultrathin multilayered polyelectrolyte films. Biomacromolecules 7 (2006) 2483-2491
116. Zhang J., Chua L.S., and Lynn D.M. Multilayered thin films that sustain the release of functional DNA under physiological conditions. Langmuir 20 (2004) 8015-8021
117. Anderson W.F. Human gene therapy. Nature 392 (1998) 25-30
118. Mikos A.G., McIntire L.V., Anderson J.M., and Babensee J.E. Host response to tissue engineered devices. Adv. Drug Deliv. Rev. 33 (1998) 111-139
119. Kao W.J. Evaluation of protein-modulated macrophage behavior on biomaterials: designing biomimetic materials for cellular engineering. Biomaterials 20 (1999) 2213-2221
120. Tseng W.C., Haselton F.R., and Giorgio T.D. Mitosis enhances transgene expression of plasmid delivered by cationic liposomes. Biochim. Biophys. Acta 1445 (1999) 53-64
121. Chen Y., Lenert P., Weeratna R., McCluskie M., Wu T., Davis H.L., and Krieg A.M. Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs. Gene Ther. 8 (2001) 1024-1032
122. Li S., Wu S.P., Whitmore M., Loeffert E.J., Wang L., Watkins S.C., Pitt B.R., and Huang L. Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors. Am. J. Physiol. 276 (1999) L796-L804
123. Yew N.S., Zhao H., Wu I.H., Song A., Tousignant J.D., Przybylska M., and Cheng S.H. Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. Mol. Ther. 1 (2000) 255-262
124. Gruneich J.A., Price A., Zhu J., and Diamond S.L. Cationic corticosteroid for nonviral gene delivery. Gene Ther. 11 (2004) 668-674
125. Cukierman E., Pankov R., and Yamada K.M. Cell interactions with three-dimensional matrices. Curr. Opin. Cell Biol. 14 (2002) 633-639
126. Cukierman E., Pankov R., Stevens D.R., and Yamada K.M. Taking cell-matrix adhesions to the third dimension. Science 294 (2001) 1708-1712
127. Debnath J., and Brugge J.S. Modelling glandular epithelial cancers in three-dimensional cultures. Nat. Rev., Cancer 5 (2005) 675-688
128. Kreeger P.K., Deck J.W., Woodruff T.K., and Shea L.D. The in vitro regulation of ovarian follicle development using alginate-extracellular matrix gels. Biomaterials 27 (2006) 714-723
129. Weaver V.M., Fischer A.H., Peterson O.W., and Bissell M.J. The importance of the microenvironment in breast cancer progression: recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay. Biochem. Cell. Biol. 74 (1996) 833-851
130. Xie Y., Yang S.T., and Kniss D.A. Three-dimensional cell-scaffold constructs promote efficient gene transfection: implications for cell-based gene therapy. Tissue Eng. 7 (2001) 585-598
131. Discher D.E., Janmey P., and Wang Y.L. Tissue cells feel and respond to the stiffness of their substrate. Science 310 (2005) 1139-1143
132. Kong H.J., Liu J., Riddle K., Matsumoto T., Leach K., and Mooney D.J. Non-viral gene delivery regulated by stiffness of cell adhesion substrates. Nat. Mater. 4 (2005) 460-464
133. Rejman J., Oberle V., Zuhorn I.S., and Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem. J. 377 (2004) 159-169
134. Z. Bengali, J.C. Cruz, L.D. Shea, Expression and internalization following vector immobilization to proteins: dependence on protein identity and density, J. Gene Med. (in press).
135. Chachisvilis M., Zhang Y.L., and Frangos J.A. G protein-coupled receptors sense fluid shear stress in endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 15463-15468
136. Gudi S., Nolan J.P., and Frangos J.A. Modulation of GTPase activity of G proteins by fluid shear stress and phospholipid composition. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 2515-2519
137. Sukharev S.I., Blount P., Martinac B., Blattner F.R., and Kung C. A large-conductance mechanosensitive channel in E. coli encoded by mscL alone. Nature 368 (1994) 265-268
138. Harris S.S., and Giorgio T.D. Convective flow increases lipoplex delivery rate to in vitro cellular monolayers. Gene Ther. 12 (2005) 512-520
139. Jang J.H., Houchin T.L., and Shea L.D. Gene delivery from polymer scaffolds for tissue engineering. Expert Rev Med Devices 1 (2004) 127-138
140. Hsiong S.X., and Mooney D.J. Regeneration of vascularized bone. Periodontol 2000 vol. 41 (2006) 109-122
141. Rebar E.J., Huang Y., Hickey R., Nath A.K., Meoli D., Nath S., Chen B., Xu L., Liang Y., Jamieson A.C., Zhang L., Spratt S.K., Case C.C., Wolffe A., and Giordano F.J. Induction of angiogenesis in a mouse model using engineered transcription factors. Nat. Med. 8 (2002) 1427-1432
142. Trentin D., Hall H., Wechsler S., and Hubbell J.A. Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 2506-2511
143. B.M. Carlson, Human embryology and developmental biology, Mosby, 1998. 2nd., 1999.
144. Nishimura I., Garrell R.L., Hedrick M., Iida K., Osher S., and Wu B. Precursor tissue analogs as a tissue-engineering strategy. Tissue Eng. 9 Suppl 1 (2003) S77-S89
145. Simmons C.A., Alsberg E., Hsiong S., Kim W.J., and Mooney D.J. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 35 (2004) 562-569
146. Ozawa C.R., Banfi A., Glazer N.L., Thurston G., Springer M.L., Kraft P.E., McDonald D.M., and Blau H.M. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J. Clin. Invest. 113 (2004) 516-527
147. Krebsbach P.H., Gu K., Franceschi R.T., and Rutherford R.B. Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo. Hum. Gene Ther. 11 (2000) 1201-1210
148. Varady P., Li J.Z., Cunningham M., Beres E.J., Das S., Engh J., Alden T.D., Pittman D.D., Kerns K.M., Kallmes D.F., and Helm G.A. Morphologic analysis of BMP-9 gene therapy-induced osteogenesis. Hum. Gene Ther. 12 (2001) 697-710
149. Elisseeff J., McIntosh W., Fu K., Blunk B.T., and Langer R. Controlled-release of IGF-I and TGF-beta1 in a photopolymerizing hydrogel for cartilage tissue engineering. J. Orthop. Res. 19 (2001) 1098-1104
150. Martin I., Suetterlin R., Baschong W., Heberer M., Vunjak-Novakovic G., and Freed L.E. Enhanced cartilage tissue engineering by sequential exposure of chondrocytes to FGF-2 during 2D expansion and BMP-2 during 3D cultivation. J. Cell. Biochem. 83 (2001) 121-128
151. Honma K., Ochiya T., Nagahara S., Sano A., Yamamoto H., Hirai K., Aso Y., and Terada M. Atelocollagen-based gene transfer in cells allows high-throughput screening of gene functions. Biochem. Biophys. Res. Commun. 289 (2001) 1075-1081
152. Ziauddin J., and Sabatini D.M. Microarrays of cells expressing defined cDNAs. Nature 411 (2001) 107-110
153. Pannier A.K., Anderson B.C., and Shea L.D. Substrate-mediated delivery from self-assembled monolayers: effect of surface ionization, hydrophilicity, and patterning. Acta Biomater. 1 (2005) 511-522
154. Yamauchi F., Kato K., and Iwata H. Micropatterned, self-assembled monolayers for fabrication of transfected cell microarrays. Biochim. Biophys. Acta 1672 (2004) 138-147
155. Heron P.M., Sutton B.M., Curinga G.M., Smith G.M., and Snow D.M. Localized gene expression of axon guidance molecules in neuronal co-cultures. J. Neurosci. Methods 159 (2007) 203-214
156. Houchin-Ray T., Whittlesey K.J., and Shea L.D. Spatially patterned gene delivery for localized neuron survival and neurite extension. Molec. Ther. 15 (2007) 705-712
157. Hollister S.J. Porous scaffold design for tissue engineering. Nat. Mater. 4 (2005) 518-524
158. Hutmacher D.W. Scaffold design and fabrication technologies for engineering tissues-state of the art and future perspectives. J. Biomater. Sci., Polym. Ed. 12 (2001) 107-124
159. Iwanaga S., Akiyama Y., Kikuchi A., Yamato M., Sakai K., and Okano T. Fabrication of a cell array on ultrathin hydrophilic polymer gels utilising electron beam irradiation and UV excimer laser ablation. Biomaterials 26 (2005) 5395-5404
160. Rosoff W.J., McAllister R., Esrick M.A., Goodhill G.J., and Urbach J.S. Generating controlled molecular gradients in 3D gels. Biotechnol. Bioeng. 91 (2005) 754-759
161. Park A., Wu B., and Griffith L.G. Integration of surface modification and 3D fabrication techniques to prepare patterned poly(l-lactide) substrates allowing regionally selective cell adhesion. J. Biomater. Sci., Polym. Ed. 9 (1998) 89-110
162. Larsen W.J. Human Embryology (1997), Chucrhill Livingston Inc. Second
163. Streicher J., and Muller G.B. 3D modelling of gene expression patterns. Trends Biotechnol. 19 (2001) 145-148
164. Ericson J., Morton S., Kawakami A., Roelink H., and Jessell T.M. Two critical periods of Sonic Hedgehog signaling required for the specification of motor neuron identity. Cell 87 (1996) 661-673
165. Gurdon J.B., Harger P., Mitchell A., and Lemaire P. Activin signalling and response to a morphogen gradient. Nature 371 (1994) 487-492
166. Saltzman W.M., and Olbricht W.L. Building drug delivery into tissue engineering. Nat. Rev. Drug Discov. 1 (2002) 177-186
167. Tanabe Y., and Jessell T.M. Diversity and pattern in the developing spinal cord. Science 274 (1996) 1115-1123
168. Cao X., and Shoichet M.S. Defining the concentration gradient of nerve growth factor for guided neurite outgrowth. Neuroscience 103 (2001) 831-840
169. DeLong S.A., Moon J.J., and West J.L. Covalently immobilized gradients of bFGF on hydrogel scaffolds for directed cell migration. Biomaterials 26 (2005) 3227-3234
170. Kapur T.A., and Shoichet M.S. Immobilized concentration gradients of nerve growth factor guide neurite outgrowth. J. Biomed. Mater. Res. A 68 (2004) 235-243
171. Tessier-Lavigne M., and Goodman C.S. The molecular biology of axon guidance. Science 274 (1996) 1123-1133
172. Shea L.D., Wang D., Franceschi R.T., and Mooney D.J. Engineered bone development from a pre-osteoblast cell line on three-dimensional scaffolds. Tissue Eng. 6 (2000) 605-617
173. Kikuchi A., and Okano T. Pulsatile drug release control using hydrogels. Adv. Drug Deliv. Rev. 54 (2002) 53-77
174. Sakiyama-Elbert S.E., and Hubbell J.A. Functional biomaterials: design of novel biomaterials. Annu. Rev. Mater. Res. 31 (2001) 183-201
175. Yamauchi F., Kato K., and Iwata H. Layer-by-layer assembly of poly(ethyleneimine) and plasmid DNA onto transparent indium-tin oxide electrodes for temporally and spatially specific gene transfer. Langmuir 21 (2005) 8360-8367
176. Zhou B.Y., Ye Z., Chen G., Gao Z.P., Zhang Y.A., and Cheng L. Inducible and Reversible Transgene Expression in Human Stem Cells after Efficient and Stable Gene Transfer. Stem Cells 25 (2006) 779-789
177. Glushakova L.G., Timmers A.M., Pang J., Teusner J.T., and Hauswirth W.W. Human blue-opsin promoter preferentially targets reporter gene expression to rat s-cone photoreceptors. Invest. Ophthalmol. Vis. Sci. 47 (2006) 3505-3513
178. He W., Qiang M., Ma W., Valente A.J., Quinones M.P., Wang W., Reddick R.L., Xiao Q., Ahuja S.S., Clark R.A., Freeman G.L., and Li S. Development of a synthetic promoter for macrophage gene therapy. Hum. Gene Ther. 17 (2006) 949-959
179. Wang X., Olmsted-Davis E., Davis A., Liu S., Li Z., Yang J., and Brunicardi F.C. Specific targeting of pancreatic islet cells in vivo by insulin-promoter-driven adenoviral conjugated reporter genes. World J. Surg. 30 (2006) 1543-1552
180. Cao X., and Shoichet M.S. Investigating the synergistic effect of combined neurotrophic factor concentration gradients to guide axonal growth. Neuroscience 122 (2003) 381-389
181. Cao R., Brakenhielm E., Pawliuk R., Wariaro D., Post M.J., Wahlberg E., Leboulch P., and Cao Y. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat. Med. 9 (2003) 604-613
182. Song S., Ewald A.J., Stallcup W., Werb Z., and Bergers G. PDGFRbeta(+) perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat. Cell Biol. 7 (2005) 870-879
183. Richardson T.P., Peters M.C., Ennett A.B., and Mooney D.J. Polymeric system for dual growth factor delivery. Nat. Biotechnol. 19 (2001) 1029-1034
184. Bunge M.B., and Pearse D.D. Transplantation strategies to promote repair of the injured spinal cord. J. Rehabil. Res. Dev. 40 (2003) 55-62
185. Schmidt C.E., and Leach J.B. Neural tissue engineering: strategies for repair and regeneration. Annu. Rev. Biomed. Eng. 5 (2003) 293-347
186. Moon L.D., Asher R.A., Rhodes K.E., and Fawcett J.W. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nat. Neurosci. 4 (2001) 465-466
187. Yick L.W., Wu W., So K.F., Yip H.K., and Shum D.K. Chondroitinase ABC promotes axonal regeneration of Clarke's neurons after spinal cord injury. NeuroReport 11 (2000) 1063-1067
188. Wood K.C., Chuang H.F., Batten R.D., Lynn D.M., and Hammond P.T. Controlling interlayer diffusion to achieve sustained, multiagent delivery from layer-by-layer thin films. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 10207-10212